| Patents for C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828) |
|---|
| 05/19/1999 | EP0916658A1 Assays utilizing improved chemiluminescent esters, thioesters and amides |
| 05/19/1999 | EP0915905A1 PROCESS FOR PREPARING 16$g(a)-HYDROXY-ESTRA-1,3,5(10)-TRIENE DERIVATIVES |
| 05/18/1999 | CA2141436C Treatment of alzheimer's disease and modulation of immune system with delta-5-androstenes |
| 05/06/1999 | EP0912186A1 Progestogen-anti-progestogen regimens |
| 05/06/1999 | EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes |
| 05/04/1999 | US5900242 Cosmetic/dermatological skin care compositions comprising S-DHEA |
| 04/21/1999 | EP0692980B1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use |
| 04/21/1999 | EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 04/15/1999 | WO1999017779A1 Methods for treating psychosis associated with glucocorticoid related dysfunction |
| 04/07/1999 | EP0906332A1 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES, PROCESS FOR THE PREPARATION THEREOF, PHARMACEUTICAL PREPARATIONS WHICH CONTAIN SAID 7$g(a)-(5-METHYLAMINOPENTYL)-ESTRATRIENES AND USE THEREOF FOR PRODUCTION OF DRUGS |
| 04/06/1999 | US5892069 Estrogenic compounds as anti-mitotic agents |
| 03/31/1999 | EP0799025B1 Intravaginal drug delivery devices for the administration of 17beta-oestradiol precursors |
| 03/30/1999 | US5888741 Computer-based design and screening of molecules using DNA interactions |
| 03/30/1999 | US5888738 Design of drugs involving receptor-ligand-DNA interactions |
| 03/25/1999 | WO1999013883A1 Androgen as a male contraceptive and non-contraceptive androgen replacement |
| 03/25/1999 | WO1999013812A1 Transdermal administration of ment |
| 03/24/1999 | EP0480950B1 Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| 03/23/1999 | CA2173457C Use of 5-alpha reductase inhibitorsand compositions for treating androg enic alopecia |
| 03/16/1999 | US5883087 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| 03/04/1999 | WO1998055074A3 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 03/03/1999 | EP0754190B1 An equilin double bond isomer from the acid isomerization of equilin |
| 02/25/1999 | WO1999009050A1 Transition metal and lewis acid complexes with steroid-receptor binding agents, in particular catechol estrogens |
| 02/24/1999 | EP0897927A1 Novel crystalline form of the progestagen - (17alpha) 17-hydroxy-11-methylene-19-nor-pregna-4,15-dien-2 0-yn-3-one(Org 30659) |
| 02/17/1999 | CN1208043A Crystalline progestagens |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | CA2244619A1 Crystalline progestagens |
| 02/03/1999 | EP0894000A1 Method for delivering estrogen |
| 02/02/1999 | US5866558 6-alkynyl steroids |
| 01/27/1999 | CN1041829C Preparation of 17a-acetylene estriol-3-cyclopentana ether |
| 01/26/1999 | CA1340342C 17-arylsteroids, process and intermediates for preparing the same, use therof as therapeutic agents and pharmaceutical compositions containing them |
| 01/20/1999 | EP0891962A1 Process for the preparation of fluorinated dicarbonyl compounds |
| 01/19/1999 | CA2215339C Immunomodulating compositions from bile for the treatment of immune system disorders |
| 01/12/1999 | US5858394 Agent for transdermal administration that contains gestodene esters |
| 01/07/1999 | EP0712412B1 15,15-dialkyl-substituted derivatives of estradiol |
| 01/05/1999 | US5855906 Uniform rate for three weeks |
| 12/29/1998 | US5854230 Antiandrogenic agents and related pharmaceutical compositions and methods of use |
| 12/29/1998 | US5854229 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 12/24/1998 | DE4244976C2 3,3-Di:alkoxy-androstanone prepn. in high yield |
| 12/22/1998 | US5852005 Tetracyclic triterpenes |
| 12/22/1998 | US5851781 Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 12/22/1998 | CA2103826C 17-(3-furyl) and 17-(4-pyridazinyl) -5.beta.,14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same |
| 12/15/1998 | US5849740 Methods for using ketoconazole and related substances in medicaments for treatment of type II diabetes |
| 12/10/1998 | WO1998055497A1 Betulinol derivatives |
| 12/10/1998 | WO1998055496A1 Non-estrogenic estradiol derivatives with an antioxidant effect |
| 12/10/1998 | WO1998055074A2 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/10/1998 | DE19723794A1 Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität Nichtestrogene derivatives of estradiol with antioxidant activity |
| 12/10/1998 | CA2293502A1 Betulinol derivatives |
| 12/10/1998 | CA2292668A1 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/09/1998 | EP0882735A1 9 Alpha-hydroxy-8 alpha-estra-1,3,5(10)-trienes and a process for their preparation |
| 12/09/1998 | EP0628052B1 Alkali metal 8,9-dehydroestrone sulfate esters |
| 12/09/1998 | CN1201038A Sulfurization for oestrogen mixture |
| 12/09/1998 | CN1041095C Steroid compounds for treatment of prostatic hypertrophy, and its medicinal composition thereof |
| 12/09/1998 | CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors |
| 12/08/1998 | US5846963 Methods for preventing progressive tissue necrosis, reperfusion injury, bacterial translocation and adult respiratory distress syndrome |
| 12/01/1998 | US5843934 Uses of estrogen compounds for the treatment of disease |
| 12/01/1998 | US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 12/01/1998 | US5843932 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 12/01/1998 | US5843931 6,7-modified 11β-aryl-4-oestrenes |
| 11/24/1998 | US5840735 Estrogen |
| 11/17/1998 | US5837700 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 11/12/1998 | WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 11/12/1998 | WO1998050412A1 Estrogenic 19-noradnrost-17-one derivatives with an aromatic b-ring |
| 11/12/1998 | CA2289008A1 Estrenes |
| 11/12/1998 | CA2288999A1 B-ring estratrienes |
| 11/11/1998 | EP0876391A1 Novel steroid esters useful against skin disorders |
| 11/10/1998 | US5834451 Remedy for myotonic dystrophy |
| 11/04/1998 | EP0875515A2 "Sulfatation of estrogen mixtures" |
| 11/04/1998 | EP0875232A1 A lipid composition containing liquid crystal phase |
| 11/03/1998 | US5831104 Steroid intermediate products and method of their production |
| 11/03/1998 | US5830886 Steroid sulphatase inhibitors |
| 10/27/1998 | US5827843 Oral dosing with a constant dose of progesterone and a variable one of the estrogen to avoid blood loss |
| 10/21/1998 | EP0871437A1 Use of boswellic acid for treating brain tumours |
| 10/21/1998 | CN1040329C 15,15-diakyl-substituted derivatives of estradiol |
| 10/20/1998 | US5824686 Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 10/20/1998 | US5824671 Vaginal atrophy, hypogonadism and loss of collagen or connective tissues |
| 10/15/1998 | WO1998045315A1 Estra-5(10),7-dienes with estrogenic activity |
| 10/15/1998 | WO1998025948A3 Processes for preparation of 9,11-epoxy steroids and intermediates useful therein |
| 10/15/1998 | CA2286457A1 Estra-5(10),7-dienes with estrogenic activity |
| 10/14/1998 | CN1195666A Intermediates of steroids, their preparation and uses |
| 10/06/1998 | US5817649 Administering reductase inhibitor and an androgen receptor antagonist |
| 09/29/1998 | US5814624 Method for obtaining estrogens from pregnant mare urine by solid-phase extraction |
| 09/17/1998 | WO1998040398A1 Synthesis of 2-alkoxyestradiols |
| 09/17/1998 | CA2283436A1 Synthesis of 2-alkoxyestradiols |
| 09/16/1998 | EP0864583A2 Alkali metal 8,9-dehydroestrone sulfate esters |
| 09/16/1998 | EP0863906A2 Heterocyclic dioxethane substrates, process for their preparation and their use |
| 09/16/1998 | EP0700291B1 15-substituted 4-azasteroids |
| 09/16/1998 | EP0624162B1 Novel steroid intermediates and processes for their preparation |
| 09/15/1998 | US5807849 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 09/11/1998 | WO1998039012A1 USE OF A 7α-METHYL-17α-ETHYNYL-ESTRANE DERIVATIVE FOR THE TREATMENT OF ATHEROSCLEROSIS |
| 09/11/1998 | CA2283418A1 Use of a 7.alpha.-methyl-17.alpha.-ethynyl-estrane derivative for the treatment of atherosclerosis |
| 09/09/1998 | EP0485392B1 Androgen derivatives for use in the inhibition of sex steroid activity |
| 09/08/1998 | US5804576 Derivatives of 5-androsten-17-ones and 5-androstan-17-ones |
| 09/02/1998 | EP0783512A4 Novel androstanes for inducing hypothalamic effects |
| 08/25/1998 | US5798348 Administered with a fatty acid; high efficiency; low toxicity |
| 08/25/1998 | US5798347 Dehydroepiandrosterone and dehydroepiandrosterone sulfate used for inhibiting proliferation of ovarian cancer |
| 08/18/1998 | US5795883 Tocopherol or trolox group |
| 08/13/1998 | WO1998034947A1 ANTIGESTAGENIC STEROIDS WITH A FLUORINATED 17α-ALKYL CHAIN |
| 08/13/1998 | DE19706061A1 Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette Antiprogestin effective steroids with 17alpha-fluorinated alkyl chain |
| 08/12/1998 | EP0857487A2 Combinations for prophylaxsis and/or treatment of benign prostatic hyperplasia containing a 17 beta-hydroxy steroid dehydrogenase (17bHSD) inhibitor and at least one further active ingredient |